Patents
Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
04/2009
04/16/2009US20090099253 Internally Masked Neopentyl Sulfonyl Ester Cyclization Release Prodrugs of Acamprosate, Compositions Thereof, and Methods of Use
04/16/2009CA2702182A1 In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells
04/15/2009EP2046728A1 Process for preparing pregabalin and its opposite enantiomer
04/15/2009EP1703909B1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
04/15/2009EP1694641B1 Prostaglandin synthesis
04/15/2009EP1590492B1 Tanning agents and preservatives
04/14/2009US7518003 Reacting 3,4-dihydro-2-alkoxy-2H-pyran with hydrogen in the presence of a catalyst under acidic condition; Grignard reaction solvent or polymer solvent
04/14/2009US7517981 heating an aqueous solution of 1,5-D-anhydrofructose at an acidic pH, in the presence of antioxidant selected from ascorbic acid, erythorbic acid, ethylenediamine tetraacetic acid and their salts
04/09/2009WO2008142155A3 Method for preparing c-6 phosphorylated d-aldohexoses and c-6 phosphorylated d-aldohexoses derivatives and new c-6 phosphorylated d-aldohexoses derivatives
04/08/2009CN101402554A 2- and 2,5-substituted phenylketo-enols
04/08/2009CN100475778C Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
04/08/2009CN100475206C Compounds useful in the treatment of anthrax and inhibiting lethal factor
04/07/2009CA2453382C Mannitol and glucitol derivatives
04/02/2009WO2008153784A3 Hydroxybenzyl or hydroxypyranonemethyl esters as tyrosinase inhibitors
04/02/2009CA2697580A1 Octahydropentalene compounds as chemokine receptor antagonists
04/01/2009EP2042171A1 Therapeutic or prophylactic agent for allergic dermatitis
04/01/2009EP2041108A1 4-hydroxythiobenzamide derivatives of drugs
04/01/2009EP2040690A1 Inhibitors of cxcr2
04/01/2009CN101397313A Maillard reaction intermediate, preparation method and use thereof
03/2009
03/26/2009WO2009038719A1 Process for the preparation of renin inhibitors
03/26/2009WO2009038715A1 Process for the preparation of renin inhibitors
03/26/2009WO2008126943A3 Method for manufacturing neuraminic acid derivatives
03/26/2009US20090082406 Cancer Therapy
03/25/2009EP2039687A1 Therapeutic or prophylactic agent for multiple sclerosis
03/25/2009EP1641740B1 Method for producing an optically active nitro compound
03/25/2009EP1592680B9 2-phenylpyran-4-one derivatives as selective cox-2 inhibitors
03/25/2009CN100471849C Grignard reaction method in production of maltol
03/25/2009CN100471848C Long-chain alkoxy alkyl substituted sialic acid derivatives and preparing method thereof
03/25/2009CN100471832C Compound for preparing protease inhibitor
03/19/2009WO2009016375A3 Polyglycerol ethers of sorbitan carboxylic acid esters
03/19/2009WO2009013764A3 Process for producing 6(r)-[2-(8'(s)-2 ',2 '-dimethylbutyryloxy-2'(s),6'(r)-dimethyl-1,2,6,7', 8',8a'(r)- hexahydronaphthyl-l'(s))ethyl]-4(r)-hydroxy-3,4,5,6- tetrahydro-2h-pyran-2-one
03/19/2009WO2008145656A3 Products, the use thereof in the treatment of textiles, and the production thereof
03/19/2009US20090076134 Deuterium-enriched simvastatin
03/19/2009US20090076062 Organic Compounds
03/19/2009US20090075327 Methods for improving secondary metabolite production in fungi
03/18/2009EP2035011A2 C-glycolipids with enhanced th-1 profile
03/18/2009EP1805129B1 (biphenyl) carboxylic acids and derivatives thereof
03/18/2009CN101389619A Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof
03/18/2009CN100469761C Cycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals
03/17/2009US7504537 osteoarthritis or rheumatoid arthritis
03/17/2009US7504434 3-(acetylamino)-4-{[amino(imino)methyl]amino}-6-carboxy-3,4-dihydro-2H-pyran-2-yl)-dimer; viricide; influenza A or B infection, parainfluenza, mumps or Newcastle disease, myxovirus infections; stability; long time in lungs
03/17/2009US7504425 Compounds useful in the treatment of anthrax and inhibiting lethal factor
03/12/2009WO2009031437A1 Tetra- or penta-cyclic liquid crystalline compound having lateral fluorine, liquid crystal composition, and liquid crystal display element
03/12/2009WO2009030716A1 Piperazine derivative having affinity for the histamine h3 receptor
03/12/2009US20090069580 Alkene Hydrofunctionalization Reactions
03/12/2009US20090069578 Novel asymmetric synthesis of (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid
03/12/2009US20090069252 C-glycoside derivatives and salts thereof
03/12/2009US20090068587 (Meth) acrylamide derivative, polymer, chemically amplified photosensitive resin composition, and patterning method
03/12/2009US20090065739 Liquid crystal compound having chloronaphthalene moiety, liquid crystal composition, and optical device
03/12/2009CA2697941A1 Piperazine derivative having affinity for the histamine h3 receptor
03/11/2009EP2033637A1 Therapeutic or prophylactic agent for leukemia
03/11/2009EP2032551A1 Antitumoral dihydropyran-2-one compounds
03/11/2009CN101384576A Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
03/11/2009CN101381356A Preparation method of simvastatin
03/11/2009CN101381355A Pyran derivate grafted yellow humic acid degradation products and preparation method thereof
03/10/2009CA2374999C Method for separating analogous organic compounds
03/10/2009CA2345069C 2-phenylpyran-4-one derivatives
03/05/2009WO2009028284A1 PROCESS FOR PRODUCTION OF (R)-2-ALKYLCYCLOPENTANONE AND (R)-δ-LACTONE
03/05/2009WO2008156828A8 Renin inhibitors
03/05/2009WO2008156817A8 Renin inhibitors
03/05/2009WO2008156816A8 Renin inhibitors
03/05/2009US20090062553 Process and Intermediates Useful in the Preparation of Statins, Particularly Atorvastatin
03/04/2009CN101379047A Preparation of delmopinol
03/04/2009CN101376652A Novel triterpenoid schisanlactone H and extracting and separating method thereof
03/04/2009CN101376637A High cubane diamide compound and use thereof
03/03/2009US7498292 Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof
02/2009
02/26/2009WO2009024550A1 N-benzyl, n' -arylcarbonylpiperazine derivatives as lxr modulators
02/26/2009US20090053641 Charge control agent and related art
02/26/2009CA2694604A1 N-benzyl, n' -arylcarbonylpiperazine derivatives as lxr modulators
02/25/2009EP2027100A2 Cyclic hydrofluoroether compounds and processes for their preparation and use
02/25/2009EP1934195B1 Method for producing lactones
02/19/2009WO2009021943A2 Novel preparation process
02/19/2009US20090048335 Process for preparing simvastatin
02/19/2009DE102007038251A1 Neues Herstellverfahren New manufacturing process
02/19/2009CA2696257A1 Novel preparation process
02/18/2009EP2024352A1 Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
02/18/2009EP1539727B1 Compounds, compositions, and methods for treating cellular proliferative diseases
02/18/2009EP1399431B1 Novel nitriles useful as reversible inhibitors of cysteine proteases
02/17/2009US7491833 Valerolactone compounds and perfume composition
02/17/2009US7491723 Alkanol and cycloalkanol-amine derivatives and methods of their use
02/17/2009US7491705 ((1S)-1-((((1S)-1-benzyl-2,3-dioxo-3-(cyclopropylamino)propyl)amino)carbonyl)-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester; ischemic disease, immunologic disease, multiple sclerosis, Alzheimer's disease, osteoporosis, diseases caused by brain tissue damage, cataract, glaucoma
02/17/2009CA2416769C Process for preparing discodermolide and analogues thereof
02/12/2009WO2009019900A1 Large-scale purification method for 2-pyrone-4,6-dicarboxylic acid
02/12/2009WO2005040107A3 Methods for making simvastatin and intermediates
02/12/2009US20090043115 Process for Producing Simvastatin
02/12/2009US20090043101 Process for production of 5-chloro-2,4-dihydroxypyridine
02/12/2009US20090042837 Leptomycin B; antiproliferative agents; antitumor agents; antcarcinogenic agents; inhibiting the export of a protein from the nucleus of a cell via a CRM1-mediated process; tissue-targeted therapy; cancer of human breast, lung, ovaries, prostate, and bladder, and leukemia cell
02/11/2009EP2021333A2 Anti-proliferative compounds deriving from a 3-aryl-coumarine or 3-aryl-quinolin-2-one and uses thereof
02/11/2009CN101362744A Sialic acid analogue and application thereof in anti-influenza virus medicament
02/05/2009WO2009016375A2 Polyglycerol ethers of sorbitan carboxylic acid esters
02/05/2009US20090036691 Analogs of dicodermolide and dictyostatin-1, intermediates therefor and methods of synthesis thereof
02/05/2009US20090035702 Process for producing compound having acid-labile group
02/05/2009US20090035700 Tertiary alcohol derivative, polymer compound and photoresist composition
02/04/2009CN101360711A L-phenylalanine derivatives and its application as integrin antagonists
02/04/2009CN100457729C 2,4-dihalogen-6-(c2-c3-alkyl)-phenyl substituted tetramic acid derivatives
02/03/2009US7485644 hydroxy{(1S)-4-pyrimidin-2-yl-1-[({4-[5-(2,2,2-trifluoroethoxy)pyrimidin-2-yl]piperazin-1-yl}sulfonyl)methyl]butyl}formamide; collagenase 3 inhibitor; tissue remodelling such as embryonic development, bone formation and uterine remodelling during menstruation
02/03/2009CA2382435C Novel herbicidally active phenyl-substituted heterocycles
01/2009
01/29/2009WO2008116339A3 Organic compounds
01/28/2009EP1711508B1 6r-(3,6-dideoxy-l-arabino-hexopyranosyloxy)heptanoic acid, preparation process for the same and dauer effect thereof
01/28/2009CN100455566C Novel derivatives of aminocyclohexane
1 ... 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 ... 129